The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
RDT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Retail Offer

5 Sep 2023 17:02

RNS Number : 4680L
Rosslyn Data Technologies PLC
05 September 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO US PERSONS OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF EU REGULATION 596/2014 WHICH FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.

 

Rosslyn Data Technologies plc

("Rosslyn", the "Group" or the "Company")

 

Result of Retail Offer

 

Further to the announcement dated 30 August 2023, Rosslyn (AIM: RDT), the provider of a leading cloud-based enterprise data analytics platform, announces that, following the closing of the Retail Offer by BookBuild earlier today, 3,101,200 Retail Offer Shares will be issued at 0.5 pence per Retail Offer Share in connection with the Retail Offer.

 

The Company notes that approximately 89 per cent. of the £3.3 million raised via the conditional Placing and Subscription, and the issue of Convertible Loan Notes comprised existing shareholders in the Company. Furthermore, the issue price of 0.5 pence per Retail Offer Share represented a nil discount to the closing mid-market price on 29 August 2023, being the latest practicable date prior to the date of the announcement of the Fundraise.

 

Consequently, 517,000,000 Placing Shares, 23,000,000 Subscription Shares and 3,101,200 Retail Offer Shares, resulting in a total of 543,101,200 Fundraising Shares, will be issued in relation to the Placing, Subscription and Retail Offer, raising total gross proceeds of approximately £3.32 million.

 

The Fundraise is conditional on, inter alia, the passing of the Resolutions by Shareholders at the General Meeting to be held on 18 September 2023. It is expected that First Admission of the Fundraising Shares to trading on AIM will occur no later than 8.00 a.m. on 19 September 2023.

 

Second Admission will occur after the Consolidation is effective and is expected to occur at 8.00 a.m. on 20 September 2023 (or such later times(s) and/or date(s) as Cenkos and the Company may agree).

 

The Fundraising Shares and the New Consolidated Ordinary Shares will, when issued, be credited as fully paid up and will have the same rights as the Existing Ordinary Shares including, voting, dividend, return of capital and other rights, and will on issue be free of all claims, liens, charges, encumbrances and equities.

 

Following Second Admission, the total number of New Consolidated Ordinary Shares in issue will be 17,659,275 with each New Consolidated Ordinary Share carrying the right to one vote. There are, and following Second Admission will be, no New Consolidated Ordinary Shares held in treasury and therefore the total number of voting rights in the Company will be 17,659,275. The above figure may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure, Guidance and Transparency Rules.

 

Capitalised terms used but not defined in this announcement have the same meanings as set out in the circular to Shareholders dated 31 August 2023.

 

For further information please contact:

 

Rosslyn

Paul Watts, Chief Executive Officer

James Appleby, Chairman

+44 (0)20 3285 8008

 

Cenkos Securities (Nominated adviser and Broker)

Stephen Keys/Camilla Hume/George Lawson

 

+44 (0)20 7397 8900

Gracechurch Group (Financial PR)

Claire Norbury/Anysia Virdi

+44 (0)20 4582 3500

 

Important Notices

The content of this announcement has been prepared by, and is the sole responsibility of, the Company.

This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into or from the United States (including its territories and possessions, any state of the United States and the District of Columbia (the "United States" or "US")), Australia, Canada, Japan, the Republic of South Africa, any member state of the EEA or any other jurisdiction where to do so might constitute a violation of the relevant laws or regulations of such jurisdiction.

The Retail Offer Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act") or under the applicable state securities laws of the United States and may not be offered or sold directly or indirectly in or into the United States or to or for the account or benefit of any US person (within the meaning of Regulation S under the US Securities Act) (a "US Person"). No public offering of the Retail Offer Shares is being made in the United States. The Retail Offer Shares are being offered and sold outside the United States in "offshore transactions", as defined in, and in compliance with, Regulation S under the US Securities Act. In addition, the Company has not been, and will not be, registered under the US Investment Company Act of 1940, as amended.

This announcement does not constitute an offer to sell or issue or a solicitation of an offer to buy or subscribe for Retail Offer Shares in the United States, Australia, Canada, New Zealand, Japan, the Republic of South Africa, any member state of the EEA or any other jurisdiction in which such offer or solicitation is or may be unlawful. No public offer of the securities referred to herein is being made in any such jurisdiction.

The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

Cenkos Securities plc ("Cenkos") which is authorised and regulated in the United Kingdom by the Financial Conduct Authority and is a member of the London Stock Exchange, is acting as nominated adviser and broker for the Company and for no-one else and will not regard any other person (whether or not a recipient of this announcement) as its client in relation to the Placing, Retail Offer and Admission and will not be responsible to anyone other than the Company for providing the protections afforded to its clients, nor for providing advice in connection with the Placing, Retail Offer, Admission and the other arrangements referred to in this announcement.

The value of Ordinary Shares and the income from them is not guaranteed and can fall as well as rise due to stock market and currency movements. When you sell your investment, you may get back less than you originally invested. Figures refer to past performance and past performance is not a reliable indicator of future results. Returns may increase or decrease as a result of currency fluctuations.

Certain statements in this announcement are forward-looking statements which are based on the Company's expectations, intentions and projections regarding its future performance, anticipated events or trends and other matters that are not historical facts. These forward-looking statements, which may use words such as "aim", "anticipate", "believe", "intend", "estimate", "expect" and words of similar meaning, include all matters that are not historical facts. These forward-looking statements involve risks, assumptions and uncertainties that could cause the actual results of operations, financial condition, liquidity and dividend policy and the development of the industries in which the Company's businesses operate to differ materially from the impression created by the forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Given those risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements.

These forward-looking statements speak only as at the date of this announcement and cannot be relied upon as a guide to future performance. The Company and Cenkos expressly disclaim any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Conduct Authority, the London Stock Exchange or applicable law.

The information in this announcement is for background purposes only and does not purport to be full or complete. None of Cenkos or any of its affiliates, accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to this announcement, including the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of the announcement or its contents or otherwise arising in connection therewith. Cenkos and its affiliates, accordingly disclaim all and any liability whether arising in tort, contract or otherwise which they might otherwise be found to have in respect of this announcement or its contents or otherwise arising in connection therewith.

Any indication in this announcement of the price at which the Ordinary Share have been bought or sold in the past cannot be relied upon as a guide to future performance. Persons needing advice should consult an independent financial adviser. No statement in this announcement is intended to be a profit forecast and no statement in this announcement should be interpreted to mean that earnings or target dividend per share of the Company for the current or future financial years would necessarily match or exceed the historical published earnings or dividends per share of the Company.

Neither the content of the Company's website (or any other website) nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement. The Retail Offer Shares to be issued or sold pursuant to the Retail Offer will not be admitted to trading on any stock exchange other than the London Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROILAMFTMTMMBBJ
Date   Source Headline
12th Jan 20235:24 pmRNSHolding(s) in Company
14th Dec 20224:16 pmRNSGrant of Options
6th Dec 20221:37 pmRNSResult of Annual General Meeting
11th Nov 20224:24 pmRNSNotice of Annual General Meeting
7th Nov 20227:00 amRNSTwo Contract Wins
1st Nov 202211:06 amRNSSecond Price Monitoring Extn
1st Nov 202211:02 amRNSSale of Integritie
1st Nov 202211:00 amRNSPrice Monitoring Extension
31st Oct 20224:51 pmRNSPublication of Annual Report
31st Oct 20223:07 pmRNSFinal Results
10th Oct 20224:41 pmRNSSecond Price Monitoring Extn
10th Oct 20224:36 pmRNSPrice Monitoring Extension
3rd Oct 20227:00 amRNSSale of Langdon Systems
29th Sep 20227:00 amRNSRosslyn wins £500k contract
22nd Aug 20227:00 amRNSFirst contract secured with Chain IQ
2nd Aug 20222:30 pmRNSInvestor Webinar
29th Jun 20227:00 amRNSBusiness Update
31st Jan 20227:00 amRNSHalf-year Report
14th Jan 20229:05 amRNSSecond Price Monitoring Extn
14th Jan 20229:00 amRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSTrading Statement
28th Oct 20214:15 pmRNSResult of AGM
4th Oct 20219:34 amRNSAnnual Report and AGM Notice
30th Sep 20217:00 amRNSFinal Results
13th Sep 20211:59 pmRNSHolding(s) in Company
16th Aug 202111:27 amRNSGrant of Options
5th Jul 20217:00 amRNSDirectorate Change
4th Jun 20217:00 amRNSBoard Change
4th Jun 20217:00 amRNSTrading Update
6th Apr 20217:00 amRNSDirectorate Change
23rd Mar 20215:54 pmRNSExercise of Options
4th Mar 20217:00 amRNSChange of auditor
12th Jan 20217:00 amRNSHalf-year Report
21st Dec 20207:00 amRNSLaunch of CustomsCloudTM product
11th Nov 20207:00 amRNSContract Win
29th Oct 20204:45 pmRNSResult of AGM
30th Sep 20209:20 amRNSNotice of AGM
29th Sep 202010:15 amRNSHolding(s) in Company
28th Sep 20204:33 pmRNSChange of Registered Office
25th Sep 202012:01 pmRNSIssue of Equity
24th Sep 20207:00 amRNSDirector/PDMR Dealing
22nd Sep 20207:00 amRNSAudited Results for the year ended 30 April 2020
1st Sep 20207:00 amRNSBoard Update
28th Aug 20204:42 pmRNSHolding(s) in Company
17th Aug 20207:00 amRNSAppointment of Chief Customer Officer
11th Aug 20209:06 amRNSSecond Price Monitoring Extn
11th Aug 20209:01 amRNSPrice Monitoring Extension
7th Jul 20207:00 amRNSStrengthening client relationships during COVID-19
25th Jun 20207:00 amRNSContract Renewals
16th Jun 20209:01 amRNSDirector/PDMR Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.